Campbell Soup could be poised to benefit from an uptick in GLP-1 drug usage, according to Bernstein.
Among the 20 analysts covering Campbell, only five have a strong buy or buy rating, while 12 have a hold rating.
In addition, the analyst anticipates that reduced chocolate consumption from GLP-1 intake may hinder U.S. chocolate volumes by 2% to 3%.
"Unfortunately, chocolate category volumes remain stubbornly negative and Hershey's chocolate volumes also remain weak despite lapping easier and easier comparables in recent months," Howard continued.
Meanwhile, only four have a strong buy or buy rating, and its average target of $202.14 implies a gain of about 5% ahead.
Persons:
Campbell, Bernstein, Eli Lilly's Mounjaro, Alexia Howard, Milano, Howard, they've
Organizations:
Nordisk's Ozempic, Hershey
Locations:
GLP